Massimo Serra

11.8k total citations
188 papers, 8.6k citations indexed

About

Massimo Serra is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Massimo Serra has authored 188 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Molecular Biology, 87 papers in Pulmonary and Respiratory Medicine and 59 papers in Oncology. Recurrent topics in Massimo Serra's work include Sarcoma Diagnosis and Treatment (83 papers), Bone Tumor Diagnosis and Treatments (20 papers) and Cancer Genomics and Diagnostics (18 papers). Massimo Serra is often cited by papers focused on Sarcoma Diagnosis and Treatment (83 papers), Bone Tumor Diagnosis and Treatments (20 papers) and Cancer Genomics and Diagnostics (18 papers). Massimo Serra collaborates with scholars based in Italy, United States and Netherlands. Massimo Serra's co-authors include Piero Picci, Katia Scotlandi, Maria Cristina Manara, Claudia Maria Hattinger, Stefania Benini, Nicola Baldini, Pier‐Luigi Lollini, Daniela Maurici, Stefano Ferrari and Pancras C.W. Hogendoorn and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Massimo Serra

186 papers receiving 8.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Massimo Serra 4.3k 3.2k 2.5k 2.0k 893 188 8.6k
Kazuki Nabeshima 3.0k 0.7× 2.2k 0.7× 2.0k 0.8× 1.2k 0.6× 395 0.4× 294 7.3k
Brygida Berse 6.3k 1.5× 1.1k 0.3× 1.9k 0.8× 2.3k 1.1× 940 1.1× 70 10.0k
David R. Rowley 2.6k 0.6× 2.4k 0.7× 1.9k 0.8× 1.2k 0.6× 384 0.4× 112 6.4k
William P. Schiemann 6.8k 1.6× 1.3k 0.4× 3.5k 1.4× 2.4k 1.2× 435 0.5× 132 11.1k
Eiji Ikeda 4.1k 1.0× 1.2k 0.4× 1.0k 0.4× 1.7k 0.9× 617 0.7× 228 8.5k
Carole Perruzzi 4.8k 1.1× 985 0.3× 1.3k 0.5× 1.6k 0.8× 1.4k 1.6× 31 7.9k
Mika Watanabe 1.8k 0.4× 1.3k 0.4× 1.4k 0.6× 1.1k 0.5× 552 0.6× 344 6.9k
Alessandro Olivi 2.3k 0.5× 1.9k 0.6× 1.7k 0.7× 1.0k 0.5× 405 0.5× 401 11.9k
Rex C. Haydon 4.4k 1.0× 836 0.3× 1.3k 0.5× 1.1k 0.6× 765 0.9× 83 7.5k
Qian Tao 6.8k 1.6× 937 0.3× 3.2k 1.3× 2.1k 1.0× 322 0.4× 297 11.0k

Countries citing papers authored by Massimo Serra

Since Specialization
Citations

This map shows the geographic impact of Massimo Serra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Serra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Serra more than expected).

Fields of papers citing papers by Massimo Serra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Serra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Serra. The network helps show where Massimo Serra may publish in the future.

Co-authorship network of co-authors of Massimo Serra

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Serra. A scholar is included among the top collaborators of Massimo Serra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Serra. Massimo Serra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palmerini, Emanuela, Maria Rosaria Sapienza, Stefano Pileri, et al.. (2024). Phase II study in pediatric and AYA patients with non-metastatic high-grade extremity osteosarcoma with a risk-adapted strategy based on P-glycoprotein (ISG/OS-2): A correlative study on tumour immune microenvironment.. Journal of Clinical Oncology. 42(16_suppl). 11530–11530. 1 indexed citations
2.
Hattinger, Claudia Maria, Iris C. Salaroglio, Martina Godel, et al.. (2023). Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma. International Journal of Molecular Sciences. 24(1). 799–799. 8 indexed citations
3.
Vanni, Silvia, Valentina Fausti, Eugenio Fonzi, et al.. (2023). Unveiling the Genomic Basis of Chemosensitivity in Sarcomas of the Extremities: An Integrated Approach for an Unmet Clinical Need. International Journal of Molecular Sciences. 24(8). 6926–6926. 17 indexed citations
4.
Serra, Massimo, et al.. (2021). Impact of ABC Transporters in Osteosarcoma and Ewing’s Sarcoma: Which Are Involved in Chemoresistance and Which Are Not?. Cells. 10(9). 2461–2461. 14 indexed citations
5.
Gazzano, Elena, Ilaria Buondonno, Alessandro Marengo, et al.. (2019). Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts. Cancer Letters. 456. 29–39. 54 indexed citations
6.
Martella, Elisa, Claudia Ferroni, Andrea Guerrini, et al.. (2018). Functionalized Keratin as Nanotechnology-Based Drug Delivery System for the Pharmacological Treatment of Osteosarcoma. International Journal of Molecular Sciences. 19(11). 3670–3670. 42 indexed citations
7.
Costa, Maria Eugénia Marques Da, Estelle Daudigeos‐Dubus, Anne Gomez‐Brouchet, et al.. (2018). Establishment and characterization of in vivo orthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG mice. Cancer Medicine. 7(3). 665–676. 12 indexed citations
8.
Buondonno, Ilaria, Elena Gazzano, Sae Rin Jean, et al.. (2016). Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma. Molecular Cancer Therapeutics. 15(11). 2640–2652. 83 indexed citations
9.
Pita, Guillermo, Ana Patiño‐García, Purificación García‐Miguel, et al.. (2016). Identification of genetic variants in pharmacokinetic genes associated with Ewing Sarcoma treatment outcome. Annals of Oncology. 27(9). 1788–1793. 8 indexed citations
10.
Hattinger, Claudia Maria, Marilù Fanelli, Elisa Tavanti, et al.. (2015). Advances in emerging drugs for osteosarcoma. Expert Opinion on Emerging Drugs. 20(3). 495–514. 77 indexed citations
11.
Fanelli, Marilù, Claudia Maria Hattinger, Serena Vella, et al.. (2015). Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma. Current Cancer Drug Targets. 16(3). 261–274. 47 indexed citations
12.
Guerzoni, Clara, Stefano Amatori, Luca Giorgi, et al.. (2014). An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas. BMC Cancer. 14(1). 137–137. 16 indexed citations
13.
Buddingh, Emilie P., Marieke L. Kuijjer, R.A.J. Duim, et al.. (2011). Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents. Clinical Cancer Research. 17(8). 2110–2119. 376 indexed citations
14.
SAU, A. C., Giuseppe Filomeni, Silvia Pezzola, et al.. (2011). Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell lines. Molecular BioSystems. 8(4). 994–1006. 60 indexed citations
15.
Scotlandi, Katia, Daniel Remondini, Gastone Castellani, et al.. (2009). Overcoming Resistance to Conventional Drugs in Ewing Sarcoma and Identification of Molecular Predictors of Outcome. Journal of Clinical Oncology. 27(13). 2209–2216. 102 indexed citations
16.
Perbal, Bernard, Monia Zuntini, Diana Zambelli, et al.. (2008). Prognostic Value of CCN3 in Osteosarcoma. Clinical Cancer Research. 14(3). 701–709. 49 indexed citations
17.
Pasello, Michela, Francesca Michelacci, Isabella Scionti, et al.. (2008). Overcoming Glutathione S -Transferase P1–Related Cisplatin Resistance in Osteosarcoma. Cancer Research. 68(16). 6661–6668. 105 indexed citations
18.
Manara, Maria Cristina, Cinzia Zucchini, Paola De Sanctis, et al.. (2007). Caveolin-1 Reduces Osteosarcoma Metastases by Inhibiting c-Src Activity and Met Signaling. Cancer Research. 67(16). 7675–7685. 75 indexed citations
19.
Manara, Maria Cristina, Bernard Perbal, Stefania Benini, et al.. (2002). The Expression of ccn3(nov) Gene in Musculoskeletal Tumors. American Journal Of Pathology. 160(3). 849–859. 94 indexed citations
20.
Giovannini, Marco, Jaclyn A. Biegel, Massimo Serra, et al.. (1994). EWS-erg and EWS-Fli1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with variant translocations.. Journal of Clinical Investigation. 94(2). 489–496. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuki Nabeshima Breakdown of academic impact, for papers by Brygida Berse Breakdown of academic impact, for papers by David R. Rowley Breakdown of academic impact, for papers by William P. Schiemann Breakdown of academic impact, for papers by Eiji Ikeda Breakdown of academic impact, for papers by Carole Perruzzi Breakdown of academic impact, for papers by Mika Watanabe Breakdown of academic impact, for papers by Alessandro Olivi Breakdown of academic impact, for papers by Rex C. Haydon Breakdown of academic impact, for papers by Qian Tao
Rankless by CCL
2026